论文部分内容阅读
目的观察痰热清注射液治疗2型登革热临床疗效。方法将我院收治的2型登革热患者随机为治疗组与对照组,各36例。对照组予对症支持治疗和及时防治各种并发症,治疗组加用痰热清注射液,两组疗程均5 d。结果治疗组出现肝肾功能损害、肺部感染等并发症15例,对照组为16例,两组比较亦无统计学差异(P>0.05)。两组主要症状体征消失时间无统计学差异(P>0.05)。治疗组治愈率为80.56%,对照组为83.33%,两组比较,差异无统计学意义(P>0.05)。结论痰热清注射液治疗2型登革热患者,有良好效果,且副作用少。
Objective To observe the clinical efficacy of Tanreqing Injection in treating dengue fever type 2. Methods The type 2 dengue patients admitted to our hospital were randomly divided into treatment group and control group, with 36 cases in each. The control group was symptomatic and supportive treatment and timely prevention and treatment of various complications, the treatment group plus Tanreqing injection, two courses of treatment were 5 d. Results In the treatment group, there were 15 cases of complications of liver and kidney dysfunction and pulmonary infection, and 16 cases in the control group. There was no significant difference between the two groups (P> 0.05). There was no significant difference in the disappearance time of the main symptoms and signs between the two groups (P> 0.05). The cure rate was 80.56% in the treatment group and 83.33% in the control group. There was no significant difference between the two groups (P> 0.05). Conclusion Tanreqing injection in patients with type 2 dengue fever, with good results, and less side effects.